Detalles de la búsqueda
1.
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Blood
; 141(25): 3031-3038, 2023 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37084383
2.
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.
Blood
; 139(4): 608-623, 2022 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657151
3.
Enteral nutrition optimization program for children undergoing blood & marrow transplantation: A quality improvement project.
J Pediatr Nurs
; 74: 61-68, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38000117
4.
Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.
Blood
; 135(17): 1428-1437, 2020 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31972009
5.
Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity.
Stem Cells
; 39(11): 1506-1519, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255899
6.
Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes.
J Clin Immunol
; 41(2): 414-426, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159275
7.
Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network.
Biol Blood Marrow Transplant
; 26(5): e94-e100, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32035274
8.
Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.
Br J Haematol
; 190(6): 822-836, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32133623
9.
Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation: The PEDECOR experience.
Pediatr Blood Cancer
; 67(10): e28403, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519430
10.
Cyclin-dependent kinase 5 activity is required for allogeneic T-cell responses after hematopoietic cell transplantation in mice.
Blood
; 129(2): 246-256, 2017 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28064242
11.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood
; 129(10): 1389-1393, 2017 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28049637
12.
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1022-1028, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29353109
13.
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes.
Biol Blood Marrow Transplant
; 24(10): 2056-2064, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29909152
14.
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors.
Biol Blood Marrow Transplant
; 24(5): 1099-1102, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29452245
15.
The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation.
Pediatr Transplant
; 22(2)2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29388370
16.
Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.
Biol Blood Marrow Transplant
; 23(4): 612-617, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28062216
17.
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.
Biol Blood Marrow Transplant
; 23(12): 2127-2136, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28807769
18.
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation.
Biol Blood Marrow Transplant
; 23(11): 1887-1894, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28754545
19.
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.
Biol Blood Marrow Transplant
; 23(2): 325-332, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27888014
20.
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 23(2): 211-234, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27713092